吉利德科学（Gilead Sciences)

个人简介:刘逸佺博士是一位拥有逾十年CMC经验的药物科学家，专注于口服和注射用小分子及肽类药物的分析方法开发。她目前在吉利德科学公司担任首席科学家（二级），领导多个肿瘤学、病毒学和炎症领域的早期及后期项目的分析策略制定。刘博士拥有德克萨斯农工大学的化学博士学位和北京大学的化学学士学位。她曾撰写多项IND、NDA和BLA申报中的CMC部分内容，在药物开发中展现出卓越的领导力、跨职能协作能力和技术创新能力。Yiquan Liu, Ph.D., is a pharmaceutical scientist with over 10 years of CMC experience, specializing in analytical development of oral and injectable small molecules and peptides. Currently a Principal Scientist II at Gilead Sciences, she has led analytical strategy for early and late-phase programs across oncology, virology, and inflammation. With deep expertise in chromatography, spectroscopy, and mass spectrometry, she brings strong leadership, cross-functional collaboration, and innovation to drug development. 查看更多